K. Kassir et al., Cytokine profiles of pediatric patients treated with antibiotics for pyelonephritis: Potential therapeutic impact, CL DIAG LAB, 8(6), 2001, pp. 1060-1063
Urinary tract infections are common in infants and children. Pyelonephritis
may result in serious complications, such as renal scarring, hypertension,
and renal failure. Identification of the timing of release of inflammatory
cytokines in relation to pyelonephritis and its treatment is essential for
designing interventions that would minimize tissue damage. To this end, we
measured urinary cytokine concentrations of interleukin-1 beta (IL-1 beta)
, IL-6, and IL-8 in infants and children with pyelonephritis and in healthy
children. Children that presented to our institution with presumed urinary
tract infection were given the diagnosis of pyelonephritis if they had a p
ositive urine culture, pyuria, and one or more of the following indicators
of systemic involvement: fever, elevated peripheral white blood cell count,
or elevated C-reactive protein. Urine samples were obtained at the time of
presentation prior to the administration of antibiotics, immediately after
completion of the first dose of antibiotics, and at follow up 12 to 24 h a
fter presentation. IL-1 beta, IL-6, and IL-8 concentrations were measured b
y enzyme-linked immunosorbent assay. Creatinine concentrations were also de
termined, and cytokine/creatinine ratios were calculated to standardize sam
ples. Differences between preantibiotic and follow-up cytokine/creatinine r
atios were significant for IL-1 beta, IL-6, and IL-8 (P < 0.01). Difference
s between preantibiotic and control cytokine/creatinine ratios were also si
gnificant for IL-1<beta>, IL-6, and IL-8 (P < 0.01). Our study revealed tha
t the urinary tract cytokine response to infection is intense but dissipate
s shortly after the initiation of antibiotic treatment. This suggests that
renal damage due to inflammation begins early in infection, underscoring th
e need for rapid diagnosis and intervention.